This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 May 20;27(15):2572-3; author reply 2573.

doi: 10.1200/JCO.2009.21.8198. Epub 2009 Apr 20.

CA 19-9 and Lewis antigens in pancreatic cancer

PMID: 19380435
DOI: 10.1200/JCO.2009.21.8198

Comment

CA 19-9 and Lewis antigens in pancreatic cancer

Carl D Atkins. J Clin Oncol. 2009.

. 2009 May 20;27(15):2572-3; author reply 2573.

doi: 10.1200/JCO.2009.21.8198. Epub 2009 Apr 20.

Author

PMID: 19380435
DOI: 10.1200/JCO.2009.21.8198

No abstract available

PubMed Disclaimer

Comment on

Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704.
Berger AC, Garcia M Jr, Hoffman JP, Regine WF, Abrams RA, Safran H, Konski A, Benson AB 3rd, MacDonald J, Willett CG. Berger AC, et al. J Clin Oncol. 2008 Dec 20;26(36):5918-22. doi: 10.1200/JCO.2008.18.6288. Epub 2008 Nov 24. J Clin Oncol. 2008. PMID: 19029412 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information